FcZero-rAb™ APC Anti-Human CD89 Rabbit Recombinant Antibody

CD89 FcZero-rAbTM Recombinant Antibody for FC
Cat No. APC-FcA98105

产品说明书

CloneNo. 241426E3

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

FC

IgA Fc receptor, FCAR, 241426E3

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  APC
规格: 

-/ -


经过测试的应用

Positive FC detected inhuman peripheral blood leukocytes

推荐稀释比

应用推荐稀释比
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

产品信息

APC-FcA98105 targets CD89 in FC applications and shows reactivity with human samples.

经测试应用 FC Application Description
经测试反应性 human
免疫原 Recombinant Protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 Fc fragment of IgA, receptor for
别名 IgA Fc receptor, FCAR, 241426E3
计算分子量 287 aa, 32 kDa
GenBank蛋白编号BC027953
基因名称 CD89
Gene ID (NCBI) 2204
偶联类型 APC Fluorescent Dye
最大激发/发射波长650 nm / 660 nm
形式 Liquid
纯化方式Protein A purification
储存缓冲液 PBS with 0.09% sodium azide and 0.5% BSA , pH 7.3
储存条件Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

背景介绍

FcαRI (CD89) is a member of the Fc receptor immunoglobulin superfamily, constitutively expressed on cells of the myeloid lineage like neutrophils, eosinophils, monocytes macrophages, and platelets (PMID: 28103138). CD89 expression and activation are increased in human blood phagocytes following bacterial infection, together with increased expression and association of FcRγ with CD89 (PMID: 34756952). CD89 binds both subclasses of IgA (IgA1 and IgA2) with moderate affinity, but also binds other molecules such as TfR1, C-reactive protein and bacterial ligands. CD89 represents an effective target molecule for immunotherapy mediated by bispecific antibodies (PMID: 37081893).

实验方案

Product Specific Protocols
FC protocol for APC CD89 antibody APC-FcA98105Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...